Thanks for the well wishes. Also last year I participated in a clinical trial with this same team at the Brigham. The drug trialed there is called bocidelpar. It targets a mitochondrial receptor called PPAR-δ. We’re still waiting on the results of that trial to be released and it’s probably a good 3-5 years away from FDA approval in the US if all goes well. So here’s hoping for the best